Allurion Technologies Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
41
- Stock Symbol
-
ALUR
- Investments
-
1
Allurion Technologies General Information
Description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact Information
Website
www.allurion.comCorporate Office
- 6 Boulevard Montmartre
- 75009 Paris
- France
Corporate Office
- 6 Boulevard Montmartre
- 75009 Paris
- France
Allurion Technologies Timeline
Allurion Technologies Stock Performance
As of 16-Nov-2026, Allurion Technologies’s current market cap is $1.28K with 608K shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.28K | 608K | 3.07K | -$54.75 |
Allurion Technologies Financials Summary
As of 31-Mar-2026, Allurion Technologies has a trailing 12-month revenue of $12.6M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 33,748 | 42,374 | 40,017 | 158,740 |
| Revenue | 12,597 | 15,230 | 32,110 | 53,467 |
| EBITDA | (30,577) | (27,698) | (3,219) | (71,241) |
| Net Income | (33,349) | (28,755) | (7,198) | (82,817) |
| Total Assets | 13,995 | 15,772 | 32,813 | 71,712 |
| Total Debt | 29,446 | 29,039 | 37,923 | 41,857 |
Allurion Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Allurion Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Allurion Technologies Patents
Allurion Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12245962-B2 | Balloon sealing and fill valve | Active | 12-Apr-2023 | ||
| US-20250009540-A1 | Balloon sealing and fill valve | Active | 12-Apr-2023 | ||
| US-20250177177-A1 | Balloon sealing and fill valve | Active | 12-Apr-2023 | ||
| WO-2024215922-A1 | Balloon sealing and fill valve | Inactive | 12-Apr-2023 | ||
| WO-2021159094-A1 | Fluid delivery catheter | Inactive | 07-Feb-2020 | A61F5/003 |
Allurion Technologies Signals
Allurion Technologies Acquisitions (1)
Allurion Technologies’s most recent deal was a Merger/Acquisition with Compute Health Acquisition. The deal was made on 01-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Compute Health Acquisition | 01-Aug-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Allurion Technologies ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
38.1 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Allurion Technologies FAQs
-
When was Allurion Technologies founded?
Allurion Technologies was founded in 2009.
-
Where is Allurion Technologies headquartered?
Allurion Technologies is headquartered in Paris, France.
-
What is the size of Allurion Technologies?
Allurion Technologies has 41 total employees.
-
What industry is Allurion Technologies in?
Allurion Technologies’s primary industry is Therapeutic Devices.
-
Is Allurion Technologies a private or public company?
Allurion Technologies is a Public company.
-
What is Allurion Technologies’s stock symbol?
The ticker symbol for Allurion Technologies is ALUR.
-
What is the current market cap of Allurion Technologies?
The current market capitalization of Allurion Technologies is $1.28K.
-
What is Allurion Technologies’s current revenue?
The trailing twelve month revenue for Allurion Technologies is $12.6M.
-
What is Allurion Technologies’s annual earnings per share (EPS)?
Allurion Technologies’s EPS for 12 months was -$54.75.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process